Source:http://linkedlifedata.com/resource/pubmed/id/18602210
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-10-20
|
pubmed:abstractText |
Although pectenotoxin-2 (PTX-2) is known to modify the actin cytoskeleton, very little is known about its apoptosis mechanism. In this study, we investigated whether PTX-2 induces apoptotic effects through suppression of the NF-kappaB signaling pathway in several leukemia cell types. PTX-2 significantly induced growth inhibition and apoptosis in a dose-dependent manner. Treatment with PTX-2 also significantly increased caspase-3 activity and poly (ADP-ribose) polymerase (PARP) cleavage, however caspase-3 inhibitor z-DEVD-fmk significantly inhibited PTX-2-induced cell death. These data suggest that the activation of caspase-3 is associated with PTX-2-induced apoptosis. NF-kappaB has also been shown to inhibit apoptosis in response to chemotherapeutic agents. As examined by the DNA-binding of NF-kappaB activation, we found that PTX-2 suppressed constitutive NF-kappaB activation and determined by p65 and p50 nuclear translocation, and IkappaBalpha degradation through dephosphorylation of Akt. Attenuation of constitutive NF-kappaB activity by pretreatment with pyrrolidine dithiocarbamate (PDTC), an NF-kappaB nuclear translocation inhibitor, induced significantly apoptosis in the presence of PTX-2. In addition, treatment of PTX-2 down-regulated NF-kappaB-dependent gene expression, Cox-2, IAP-1, IAP-2 and XIAP, at the transcriptional and translational level. Taken together, these results suggest that anti-cancer activities induced by PTX-2 may be mediated in part through suppression of constitutive NF-kappaB activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Furans,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrans,
http://linkedlifedata.com/resource/pubmed/chemical/pectenotoxin 2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1872-7980
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
18
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-33
|
pubmed:meshHeading |
pubmed-meshheading:18602210-Apoptosis,
pubmed-meshheading:18602210-Base Sequence,
pubmed-meshheading:18602210-Blotting, Western,
pubmed-meshheading:18602210-Cell Line, Tumor,
pubmed-meshheading:18602210-Cell Proliferation,
pubmed-meshheading:18602210-DNA Primers,
pubmed-meshheading:18602210-Electrophoretic Mobility Shift Assay,
pubmed-meshheading:18602210-Furans,
pubmed-meshheading:18602210-Humans,
pubmed-meshheading:18602210-NF-kappa B,
pubmed-meshheading:18602210-Pyrans,
pubmed-meshheading:18602210-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18602210-Signal Transduction
|
pubmed:year |
2008
|
pubmed:articleTitle |
Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.
|
pubmed:affiliation |
Department of Microbiology, College of Natural Sciences, Pusan National University, Busan, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|